Todos os estudos
RecrutamentoFASE3INTERVENCIONISTA

Abatacept in Immune Checkpoint Inhibitor Myocarditis

This study is for people who have heart inflammation (myocarditis) that has developed after receiving certain cancer treatments called immune checkpoint inhibitors. These cancer treatments work by boosting your immune system, but sometimes they can also cause it to attack the heart. We already know that standard treatments like steroids don't always fully prevent serious heart problems in these cases. This study aims to find out if an additional medicine called abatacept, given alongside steroids, can help reduce the risk of serious heart issues like heart attacks, dangerous heart rhythms, or heart failure. Participants will either receive abatacept or a dummy drug (placebo) to see which is more effective.

Em resumo

Status
Recrutamento
Fase
FASE3
Patrocinador
Hospital Geral de Massachusetts
Meta de inscrição
390
Iniciar
02 Jul 2022
Conclusão estimada
20 Apr 2027

Sobre o que é este estudo?

This study is looking at a new way to treat a specific type of heart inflammation, called myocarditis. This heart issue can sometimes happen to people undergoing certain cancer treatments. These treatments, known as immune checkpoint inhibitors, are very good at helping your body fight cancer, but occasionally they can cause your immune system to mistakenly attack other parts of the body, including your heart. When this happens, it's a serious condition.

Even with the best standard treatments currently available, such as high-dose steroids, people with this type of myocarditis can still experience serious heart problems. These might include things like a heart attack, dangerously fast or slow heartbeats, or the heart struggling to pump blood properly. Researchers have noticed that these serious heart problems are much more common in people with myocarditis caused by cancer treatment compared to other types of myocarditis.

That's where this study comes in. It's investigating if an additional medicine called abatacept can make a difference. Abatacept works by calming down parts of the immune system that might be overactive. Early research and some patient information suggest that abatacept could help reduce damage to the heart and improve outcomes for people with this type of myocarditis. This study aims to confirm these findings in a careful and organised way, comparing abatacept with a dummy drug (placebo) to see if it truly helps reduce serious heart problems when given alongside standard steroid treatment.

Pontos principais

  • This study evaluates abatacept for heart inflammation (myocarditis) from cancer treatment.
  • It aims to reduce serious heart problems in people with this condition.
  • Participants will receive either abatacept or a dummy drug alongside standard care.
  • The study includes careful monitoring during hospitalisation and follow-up.
  • It's a 'double-blind' study, meaning no one knows who gets the active drug.
  • A participação é voluntária, e você pode se retirar a qualquer momento.

Quem pode ser elegível?

To be able to take part in this study, you need to meet a few important conditions. Firstly, you must be 18 years or older. You also need to have given your consent, meaning you understand the study and agree to participate. If you're too unwell to give consent, a family member or legal guardian might be able to do so for you, as allowed by local rules.

Crucially, you must have recently (within the last six months) received an immune checkpoint inhibitor for cancer treatment. This study is specifically for people whose myocarditis developed after this type of cancer treatment. You also need to have a clear diagnosis of myocarditis and be in hospital at the time you join the study.

Finally, your heart needs to show signs of ongoing injury, which doctors will check using a blood test called troponin. This blood test result needs to be significantly higher than normal, indicating that your heart is still affected, and this high level must have been noted recently. You also need to be receiving or about to start a high dose of a steroid medication called solumedrol for your myocarditis.

Este estudo pode ser adequado para você?

Responda a estas perguntas rápidas para ver se você pode ser elegível. Este é apenas um guia — a decisão final é da equipe de pesquisa.

  1. Você tem 18 anos ou mais?
  2. Have you recently received a type of cancer treatment called an 'immune checkpoint inhibitor'?
  3. Have you been diagnosed with myocarditis (heart inflammation)?
  4. Are you currently in hospital for your myocarditis?
  5. Are you receiving or about to start high-dose steroid treatment for your heart inflammation?
  6. Does your recent blood test show ongoing signs of heart injury (high troponin level)?
Responda a todas as perguntas para ver o seu resultado.

O que envolve a participação?

If you join this study, you will either receive the study drug abatacept or a dummy drug (placebo) through an injection, alongside the standard steroid treatment your doctors are already giving you. Neither you nor your doctors will know whether you are receiving abatacept or the placebo. You'll need to remain in hospital for a period, where doctors will closely monitor your heart and overall health. This will involve regular blood tests, heart scans, and checks on your heart's electrical activity (ECGs) to see how you are responding to treatment.

During your time in the study, medical staff will carefully watch for any changes in your condition or any side effects. After you leave the hospital, there will be follow-up appointments to continue monitoring your heart health and ensure your recovery is progressing well. The total duration of your participation in the study will involve initial treatment while in hospital and then follow-up appointments over a period of time, which your study doctor will explain in detail.

Riscos e benefícios potenciais

Participating in this study might offer a potential benefit if abatacept proves to be effective in reducing serious heart problems caused by your cancer treatment. However, as with any medical study, there are potential risks, including side effects from the study drug or unknown effects. You will be closely monitored for any adverse reactions. You have the right to withdraw from the study at any time, for any reason, without it affecting your usual medical care.

Locations (31)

  • Cedars-Sinai Medical Center
    Código postal verificado
    Los Angeles, Estados Unidos· Recrutamento
  • Universidade da Califórnia em Los Angeles
    Código postal verificado
    Los Angeles, Estados Unidos· Recrutamento
  • MedStar Health Research Institute, Georgetown University
    Código postal verificado
    Washington D.C., Estados Unidos· Recrutamento
  • Centro de Câncer Moffitt
    Código postal verificado
    Tampa, Estados Unidos· Recrutamento
  • University of Chicago
    Código postal verificado
    Chicago, Estados Unidos· Recrutamento
  • Franciscan Health
    Código postal verificado
    Indianápolis, Estados Unidos· Recrutamento
  • University of Kansas Medical Center
    Código postal verificado
    Kansas City, Estados Unidos· Recrutamento
  • University of Kentucky
    Código postal verificado
    Lexington, Estados Unidos· Recrutamento
  • Maine Health
    Código postal verificado
    Portland, Estados Unidos· Recrutamento
  • Johns Hopkins
    Código postal verificado
    Baltimore, Estados Unidos· Recrutamento
  • Hospital Geral de Massachusetts
    Código postal verificado
    Boston, Estados Unidos· Recrutamento
  • Centro Médico Beth Israel Deaconess
    Código postal verificado
    Boston, Estados Unidos· Recrutamento

Perguntas frequentes

What is myocarditis?

Myocarditis is inflammation of the heart muscle, which can make it harder for your heart to pump blood effectively.

What are immune checkpoint inhibitors?

These are a type of cancer treatment that helps your body's own immune system fight cancer cells more effectively.

What is abatacept?

Abatacept is a medication that helps to quiet down an overactive immune system. It's used for some autoimmune conditions.

Will I know if I'm getting the real drug or a dummy drug?

No, neither you nor your doctors will know if you are receiving abatacept or the placebo (dummy drug) during the study. This helps ensure fair results.

What if my condition gets worse during the study?

You will be closely monitored by medical staff, and if your condition changes or worsens, your doctors will provide appropriate medical care and may remove you from the study if it's in your best interest.

Como saber mais

Hannah K Gilman, MS

Sempre consulte seu médico ou especialista antes de decidir participar de um estudo.

Interessado em participar?

Registre seu interesse

Compartilhe seus detalhes e a equipe de pesquisa para "Abatacept in Immune Checkpoint Inhibitor Myocarditis…" entrará em contato com você se você for elegível. Sempre fale com seu médico antes de concordar em participar.

Discussão

Discussão da comunidade

Desenvolvido pelo nosso fórum em community.patient.info. Por favor, seja respeitoso — isto não é um conselho médico.